These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15159528)

  • 1. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment of chemical carcinogens and thresholds.
    Neumann HG
    Crit Rev Toxicol; 2009; 39(6):449-61. PubMed ID: 19545196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy of the scientific committee on occupational exposure limits (SCOEL) in the derivation of occupational exposure limits for carcinogens and mutagens.
    Bolt HM; Huici-Montagud A
    Arch Toxicol; 2008 Jan; 82(1):61-4. PubMed ID: 18008062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses and thresholds in genotoxicity: from theories to experiments.
    Zito R
    J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive approach for integration of toxicity and cancer risk assessments.
    Butterworth BE; Bogdanffy MS
    Regul Toxicol Pharmacol; 1999 Feb; 29(1):23-36. PubMed ID: 10051416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
    Bogen KT
    Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New aspects in the classification of carcinogens.
    Foth H; Degen GH; Bolt HM
    Arh Hig Rada Toksikol; 2005 Jun; 56(2):167-75. PubMed ID: 15968833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
    Hengstler JG; Bogdanffy MS; Bolt HM; Oesch F
    Annu Rev Pharmacol Toxicol; 2003; 43():485-520. PubMed ID: 12415124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
    Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
    Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of thresholds on the risk assessment of carcinogens in food.
    Pratt I; Barlow S; Kleiner J; Larsen JC
    Mutat Res; 2009 Aug; 678(2):113-7. PubMed ID: 19442758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenic.
    Benford D; Bolger PM; Carthew P; Coulet M; DiNovi M; Leblanc JC; Renwick AG; Setzer W; Schlatter J; Smith B; Slob W; Williams G; Wildemann T
    Food Chem Toxicol; 2010 Jan; 48 Suppl 1():S2-24. PubMed ID: 20113851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.